TVTX logo

Travere Therapeutics, Inc. (TVTX) Retained Earnings

Annual Retained Earnings:

-$1.45B-$321.55M(-28.57%)
December 31, 2024

Summary

  • As of today, TVTX annual retained earnings is -$1.45 billion, with the most recent change of -$321.55 million (-28.57%) on December 31, 2024.
  • During the last 3 years, TVTX annual retained earnings has fallen by -$681.20 million (-88.93%).
  • TVTX annual retained earnings is now -2782913.46% below its all-time high of -$52.00 thousand, reached on February 1, 2008.

Performance

TVTX Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Quarterly Retained Earnings:

-$1.50B-$12.76M(-0.86%)
June 30, 2025

Summary

  • As of today, TVTX quarterly retained earnings is -$1.50 billion, with the most recent change of -$12.76 million (-0.86%) on June 30, 2025.
  • Over the past year, TVTX quarterly retained earnings has dropped by -$169.06 million (-12.69%).
  • TVTX quarterly retained earnings is now -2709553.43% below its all-time high of -$55.40 thousand, reached on May 1, 2008.

Performance

TVTX Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXbalance sheet metrics

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

TVTX Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-28.6%-12.7%
3Y3 Years-88.9%-70.8%
5Y5 Years-247.5%-239.8%

TVTX Retained Earnings Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-88.9%at low-58.3%at low
5Y5-Year-247.5%at low-223.3%at low
All-TimeAll-Time>-9999.0%at low>-9999.0%at low

TVTX Retained Earnings History

DateAnnualQuarterly
Jun 2025
-
-$1.50B(-0.9%)
Mar 2025
-
-$1.49B(-2.8%)
Dec 2024
-$1.45B(-28.6%)
-$1.45B(-4.3%)
Sep 2024
-
-$1.39B(-4.1%)
Jun 2024
-
-$1.33B(-5.6%)
Mar 2024
-
-$1.26B(-12.1%)
Dec 2023
-$1.13B(-11.0%)
-$1.13B(-8.7%)
Sep 2023
-
-$1.04B(+12.7%)
Jun 2023
-
-$1.19B(-7.8%)
Mar 2023
-
-$1.10B(-8.5%)
Dec 2022
-$1.01B(-32.4%)
-$1.01B(-6.9%)
Sep 2022
-
-$948.40M(-7.9%)
Jun 2022
-
-$878.74M(-8.3%)
Mar 2022
-
-$811.71M(-6.0%)
Dec 2021
-$765.97M(-30.7%)
-$765.97M(-7.2%)
Sep 2021
-
-$714.39M(-5.3%)
Jun 2021
-
-$678.75M(-6.1%)
Mar 2021
-
-$639.74M(-9.2%)
Dec 2020
-$585.88M(-40.7%)
-$585.88M(-26.2%)
Sep 2020
-
-$464.25M(-5.1%)
Jun 2020
-
-$441.70M(-6.3%)
Mar 2020
-
-$415.64M(+0.2%)
Dec 2019
-$416.44M(-54.2%)
-$416.44M(-7.8%)
Sep 2019
-
-$386.19M(-10.4%)
Jun 2019
-
-$349.69M(-12.4%)
Mar 2019
-
-$310.99M(-15.2%)
Dec 2018
-$270.02M(-52.0%)
-$270.02M(-2.8%)
Sep 2018
-
-$262.56M(-26.2%)
Jun 2018
-
-$208.05M(-12.0%)
Mar 2018
-
-$185.72M(-4.5%)
Dec 2017
-$177.66M
-$177.66M(-11.0%)
Sep 2017
-
-$160.04M(-12.5%)
Jun 2017
-
-$142.24M(-10.3%)
DateAnnualQuarterly
Mar 2017
-
-$129.01M(-14.1%)
Dec 2016
-$113.06M(-73.5%)
-$113.06M(-8.2%)
Sep 2016
-
-$104.45M(-55.1%)
Jun 2016
-
-$67.34M(-24.8%)
Mar 2016
-
-$53.94M(+17.2%)
Dec 2015
-$65.15M(+63.6%)
-$65.15M(-3.9%)
Sep 2015
-
-$62.68M(+62.7%)
Jun 2015
-
-$168.26M(-17.9%)
Mar 2015
-
-$142.73M(+20.3%)
Dec 2014
-$179.17M(-162.6%)
-$179.17M(-20.1%)
Sep 2014
-
-$149.13M(-15.1%)
Jun 2014
-
-$129.58M(+6.1%)
Mar 2014
-
-$138.06M(-102.3%)
Dec 2013
-$68.24M(-103.0%)
-$68.24M(-25.7%)
Sep 2013
-
-$54.30M(-25.1%)
Jun 2013
-
-$43.40M(-13.2%)
Mar 2013
-
-$38.35M(-14.1%)
Dec 2012
-$33.61M(>-9900.0%)
-$33.61M(>-9900.0%)
Nov 2011
-
-$131.80K(-2.7%)
Aug 2011
-
-$128.30K(-2.8%)
May 2011
-
-$124.80K(-2.9%)
Feb 2011
-$121.30K(-23.5%)
-$121.30K(-3.5%)
Nov 2010
-
-$117.20K(-5.1%)
Aug 2010
-
-$111.50K(-6.3%)
May 2010
-
-$104.90K(-6.8%)
Feb 2010
-$98.20K(-39.7%)
-$98.20K(-7.7%)
Nov 2009
-
-$91.20K(-7.8%)
Aug 2009
-
-$84.60K(-8.6%)
May 2009
-
-$77.90K(-10.8%)
Feb 2009
-$70.30K(-35.2%)
-$70.30K(-12.1%)
Nov 2008
-
-$62.70K(-7.4%)
Aug 2008
-
-$58.40K(-5.4%)
May 2008
-
-$55.40K
Feb 2008
-$52.00K
-

FAQ

  • What is Travere Therapeutics, Inc. annual retained earnings?
  • What is the all-time high annual retained earnings for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual retained earnings year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly retained earnings?
  • What is the all-time high quarterly retained earnings for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly retained earnings year-on-year change?

What is Travere Therapeutics, Inc. annual retained earnings?

The current annual retained earnings of TVTX is -$1.45B

What is the all-time high annual retained earnings for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual retained earnings is -$52.00K

What is Travere Therapeutics, Inc. annual retained earnings year-on-year change?

Over the past year, TVTX annual retained earnings has changed by -$321.55M (-28.57%)

What is Travere Therapeutics, Inc. quarterly retained earnings?

The current quarterly retained earnings of TVTX is -$1.50B

What is the all-time high quarterly retained earnings for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly retained earnings is -$55.40K

What is Travere Therapeutics, Inc. quarterly retained earnings year-on-year change?

Over the past year, TVTX quarterly retained earnings has changed by -$169.06M (-12.69%)
On this page